Precision Study of CLAiR AI Software
NCT: NCT07747233 · COMPLETED
Brief Summary
This multi-site precision study evaluated the performance and reproducibility of the CLAiR artificial intelligence (AI) software in identifying elevated risk of atherosclerotic cardiovascular disease (ASCVD) from retinal fundus images. Participants underwent protocol-defined retinal imaging using Topcon NW400 and NW500 cameras. The study assessed agreement and consistency of device outputs across operators and imaging conditions. No medical management decisions were made based on device results.
Frequently Asked Questions
What is Precision Study of CLAiR AI Software?
Precision Study of CLAiR AI Software is a clinical trial registered under NCT07747233. Current status: COMPLETED.
What is the status of NCT07747233?
The current status of NCT07747233 (Precision Study of CLAiR AI Software) is: COMPLETED.
When did Precision Study of CLAiR AI Software start?
Precision Study of CLAiR AI Software started on 2025-12-05.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.